ArticleLeukemia & lymphoma2017

Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose.

David A Bond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.